New scan could replace invasive test for Cushing's disease diagnosis
NCT ID NCT07108244
First seen Jan 04, 2026 · Last updated May 24, 2026 · Updated 22 times
Summary
This study compares a new, non-invasive PET-MRI scan to the current gold-standard invasive test (IPSS) for finding pituitary tumors in people with Cushing's disease. About 43 adults with confirmed ACTH-dependent hypercortisolism will receive both tests to see which more accurately identifies the tumor's location. If successful, the PET-MRI could become a safer, simpler diagnostic option.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUSHING DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Erasmus University Medical Centre
Rotterdam, South Holland, 3015, Netherlands
-
University Hospital Basel
Basel, Canton of Basel-City, 4031, Switzerland
Conditions
Explore the condition pages connected to this study.